Overview of nomenclature of nuclear receptors

Pharmacological Reviews

Volumn 58, Issue 4, 2006, Pages 685-704

  Germain, Pierre ^a,d   Staels, Bart ^a   Dacquet, Catherine ^b   Spedding, Michael ^b   Laudet, Vincent ^c  

^a INSERM   (France)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^c UNIVERSITÉ DE LYON   (France)

^d INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 4 HYDROXYTAMOXIFEN; ANTIESTROGEN; CELL NUCLEUS RECEPTOR; DEXAMETHASONE; DIMER; FURYLFURAMIDE; GW 0072; GW 6471; HORMONE ANTAGONIST; MIFEPRISTONE; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; PARTIAL AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROGESTERONE; RALOXIFENE; RETINOIC ACID; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; THIAZOLE DERIVATIVE;

ALLOSTERISM; BREAST CANCER; DNA BINDING; DRUG ACTIVATION; DRUG ACTIVITY; DRUG RESEARCH; DRUG SENSITIVITY; DRUG STRUCTURE; HUMAN; INFLAMMATION; LIGAND BINDING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN METABOLISM; PROTEIN STRUCTURE; REVIEW; STOICHIOMETRY; TRANSCRIPTION REGULATION;

ANIMALS; BINDING SITES; GENE EXPRESSION REGULATION; HUMANS; LIGANDS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TERMINOLOGY;

EID: 33751548984     PISSN: 00316997     EISSN: 15210081     Source Type: Journal    
DOI: 10.1124/pr.58.4.2     Document Type: Review

References (231)

1. Alarid ET, Bakopoulos N, and Solodin N (1999) Proteasome-mediated proteolysis of estrogen receptor: a novel component in autologous down-regulation. Mol Endocrinol 13:1522-1534.
2. Amri EZ, Bonino F, Ailhaud G, Abumrad NA, and Grimaldi PA (1995) Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes: homology to peroxisome proliferator-activated receptors. J Biol Chem 270:2367-2371.
3. Aronica SM, Kraus WL, and Katzenellenbogen BS (1994) Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci USA 91:8517-8521.
4. Baek SH, Ohgi KA, Rose DW, Koo EH, Glass CK, and Rosenfeld MG (2002) Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-κB and β-amyloid precursor protein. Cell 110:55-67.
5. Baniahmad A, Leng X, Burris TP, Tsai SY, Tsai MJ, and O'Malley BW (1995) The tau 4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing. Mol Cell Biol 15:76-86.
6. Bastien J and Rochette-Egly C (2004) Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 328:1-16.
7. Bavner A, Sanyal S, Gustafsson JA, and Treuter E (2005) Transcriptional corepression by SHP: molecular mechanisms and physiological consequences. Trends Endocrinol Metab 16:478-488.
8. Beato M, Herrlich P, and Schutz G (1995) Steroid hormone receptors: many actors in search of a plot. Cell 83:851-857.
9. Bergh JJ, Lin HY, Lansing L, Mohamed SN, Davis FB, Mousa S, and Davis PJ (2005) Integrin αVβ3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology 146:2864-2871.
10. Berry M, Metzger D, and Chambon P (1990) Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO (Eur Mol Biol Organ) J 9:2811-2818.
11. Bledsoe RK, Montana VG, Stanley TB, Delves CJ, Apolito CJ, McKee DD, Consler TG, Parks DJ, Stewart EL, Willson TM, et al. (2002) Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell 110:93-105.
12. Boonyaratanakornkit V, Scott MP, Ribon V, Sherman L, Anderson SM, Maller JL, Miller WT, and Edwards DP (2001) Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol Cell 8:269-280.
13. Bourguet W, Germain P, and Gronemeyer H (2000a) Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications. Trends Pharmacol Sci 21:381-388.
14. Bourguet W, Ruff M, Chambon P, Gronemeyer H, and Moras D (1995) Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α. Nature (Lond) 375:377-382.
15. Bourguet W, Vivat V, Wurtz JM, Chambon P, Gronemeyer H, and Moras D (2000b) Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains. Mol Cell 5:289-298.
16. Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson JA, and Carlquist M (1997) Molecular basis of agonism and antagonism in the oestrogen receptor. Nature (Lond) 389:753-758.
17. Bubulya A, Wise SC, Shen XQ, Burmeister LA, and Shemshedini L (1996) c-Jun can mediate androgen receptor-induced transactivation. J Biol Chem 271:24583-24589.
18. Castoria G, Migliaccio A, Bilancio A, Di Domenico M, de Falco A, Lombardi M, Fiorentino R, Varricchio L, Barone MV, and Auricchio F (2001) PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO (Eur Mol Biol Organ) J 20:6050-6059.
19. Cato AC, Nestl A, and Mink S (2002) Rapid actions of steroid receptors in cellular signaling pathways. Sci STKE 2002:RE9.
20. Cenni B and Picard D (1999) Ligand-independent activation of steroid receptors: new roles for old players. Trends Endocrinol Metab 10:41-46.
21. Chambon P (1996) A decade of molecular biology of retinoic acid receptors. FASEB J 10:940-954.
22. Chambon P (2005) The nuclear receptor superfamily: a personal retrospect on the first two decades. Mol Endocrinol 19:1418-1428.
23. Chang L and Karin M (2001) Mammalian MAP kinase signalling cascades. Nature (Lond) 410:37-40.
24. Charles JP, Shinoda T, and Chinzei Y (1999) Characterization and DNA-binding properties of GRF, a novel monomeric binding orphan receptor related to GCNF and βFTZ-F1. Eur J Biochem 266:181-190.
25. Chawla A, Repa JJ, Evans RM, and Mangelsdorf DJ (2001) Nuclear receptors and lipid physiology: opening the X-files. Science (Wash DC) 294:1866-1870.
26. Chen D, Huang SM, and Stallcup MR (2000) Synergistic, p160 coactivator-dependent enhancement of estrogen receptor function by CARM1 and p300. J Biol Chem 275:40810-40816.
27. Chen H, Lin RJ, Xie W, Wilpitz D, and Evans RM (1999) Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase. Cell 98:675-686.
28. Chen JD (2000) Steroid/nuclear receptor coactivators. Vitam Horm 58:391-448.
29. Chen JD and Evans RM (1995) A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature (Lond) 377:454-457.
30. Cheskis B and Freedman LP (1996) Modulation of nuclear receptor interactions by ligands: kinetic analysis using surface plasmon resonance. Biochemistry 35:3309-3318.
31. Cosma MP (2002) Ordered recruitment: gene-specific mechanism of transcription activation. Mol Cell 10:227-236.
32. Couse JF and Korach KS (1999) Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 20:358-417.
33. Cronet P, Petersen JF, Folmer R, Blomberg N, Sjoblom K, Karlsson U, Lindstedt EL, and Bamberg K (2001) Structure of the PPARα and -γ ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family. Structure 9:699-706.
34. Dace A, Zhao L, Park KS, Furuno T, Takamura N, Nakanishi M, West BL, Hanover JA, and Cheng S (2000) Hormone binding induces rapid proteasome-mediated degradation of thyroid hormone receptors. Proc Natl Acad Sci USA 97:8985-8990.
35. D'Arezzo S, Incerpi S, Davis FB, Acconcia F, Marino M, Farias RN, and Davis PJ (2004) Rapid nongenomic effects of 3,5,3′-triiodo-L-thyronine on the intracellular pH of L-6 myoblasts are mediated by intracellular calcium mobilization and kinase pathways. Endocrinology 145:5694-5703.
36. De Bosscher K, Vanden Berghe W, and Haegeman G (2001) Glucocorticoid repression of AP-1 is not mediated by competition for nuclear coactivators. Mol Endocrinol 15:219-227.
37. De Bosscher K, Vanden Berghe W, and Haegeman G (2003) The interplay between the glucocorticoid receptor and nuclear factor-κB or activator protein-1: molecular mechanisms for gene repression. Endocr Rev 24:488-522.
38. Delage-Mourroux R, Martini PG, Choi I, Kraichely DM, Hoeksema J, and Katzenellenbogen BS (2000) Analysis of estrogen receptor interaction with a repressor of estrogen receptor activity (REA) and the regulation of estrogen receptor transcriptional activity by REA. J Biol Chem 275:35848-35856.
39. Delmotte MH, Tahayato A, Formstecher P, and Lefebvre P (1999) Serine 157, a retinoic acid receptor α residue phosphorylated by protein kinase C in vitro, is involved in RXR.RARα heterodimerization and transcriptional activity. J Biol Chem 274:38225-38231.
40. Dhe-Paganon S, Duda K, Iwamoto M, Chi YI, and Shoelson SE (2002) Crystal structure of the HNF4 α ligand binding domain in complex with endogenous fatty acid ligand. J Biol Chem 277:37973-37976.
41. Dilworth FJ, Fromental-Ramain C, Yamamoto K, and Chambon P (2000) ATP-driven chromatin remodeling activity and histone acetyltransferases act sequentially during transactivation by RAR/RXR in vitro. Mol Cell 6:1049-1058.
42. DiRenzo J, Shang Y, Phelan M, Sif S, Myers M, Kingston R, and Brown M (2000) BRG-1 is recruited to estrogen-responsive promoters and cooperates with factors involved in histone acetylation. Mol Cell Biol 20:7541-7549.
43. Dreyer C, Krey G, Keller H, Givel F, Helftenbein G, and Wahli W (1992) Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68:879-887.
44. Escriva H, Delaunay F, and Laudet V (2000) Ligand binding and nuclear receptor evolution. Bioessays 22:717-727.
45. Escriva H, Safi R, Hanni C, Langlois MC, Saumitou-Laprade P, Stehelin D, Capron A, Pierce R, and Laudet V (1997) Ligand binding was acquired during evolution of nuclear receptors. Proc Natl Acad Sci USA 94:6803-6808.
46. Evans RM (2005) The nuclear receptor superfamily: a Rosetta stone for physiology. Mol Endocrinol 19:1429-1438.
47. Floyd ZE and Stephens JM (2002) Interferon-γ-mediated activation and ubiquitin-proteasome-dependent degradation of PPARγ in adipocytes. J Biol Chem 277:4062-4068.
48. Font de Mora J and Brown M (2000) AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. Mol Cell Biol 20:5041-5047.
49. Freeman BC and Yamamoto KR (2002) Disassembly of transcriptional regulatory complexes by molecular chaperones. Science (Wash DC) 296:2232-2235.
50. Fryer CJ and Archer TK (1998) Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. Nature (Lond) 393:88-91.
51. Fu M, Wang C, Wang J, Zhang X, Sakamaki T, Yeung YG, Chang C, Hopp T, Fuqua SA, Jaffray E, et al. (2002) Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and transrepression function. Mol Cell Biol 22:3373-3388.
52. Fujiki R, Kim MS, Sasaki Y, Yoshimura K, Kitagawa H, and Kato S (2005) Ligand-induced transrepression by VDR through association of WSTF with acetylated histones. EMBO (Eur Mol Biol Organ) J 24:3881-3894.
53. Gampe RT Jr, Montana VG, Lambert MH, Miller AB, Bledsoe RK, Milburn MV, Kliewer SA, Willson TM, and Xu HE (2000) Asymmetry in the PPARγ/RXRα crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. Mol Cell 5:545-555.
54. Gehin M, Vivat V, Wurtz JM, Losson R, Chambon P, Moras D, and Gronemeyer H (1999) Structural basis for engineering of retinoic acid receptor isotype-selective agonists and antagonists. Chem Biol 6:519-529.
55. Germain P, Iyer J, Zechel C, and Gronemeyer H (2002) Coregulator recruitment and the mechanism of retinoic acid receptor synergy. Nature (Lond) 415:187-192.
56. Germain P, Kammerer S, Perez E, Peluso-Iltis C, Tortolani D, Zusi FC, Starrett J, Lapointe P, Daris JP, Marinier A, et al. (2004) Rational design of RAR-selective ligands revealed by RARβ crystal stucture. EMBO (Eur Mol Biol Organ) Rep 5:877-882.
57. Gianni M, Bauer A, Garattini E, Chambon P, and Rochette-Egly C (2002) Phosphorylation by p38MAPK and recruitment of SUG-1 are required for RA- induced RARγ degradation and transactivation. EMBO (Eur Mol Biol Organ) J 21:3760-3769.
58. Giguere A, Fortier S, Beaudry C, Gallo-Payet N, and Bellabarba D (1996) Effect of thyroid hormones on G proteins in synaptosomes of chick embryo. Endocrinology 137:2558-2564.
59. Giguere V, Hollenberg SM, Rosenfeld MG, and Evans RM (1986) Functional domains of the human glucocorticoid receptor. Cell 46:645-652.
60. Giguere V, McBroom LD, and Flock G (1995) Determinants of target gene specificity for RORα1: monomeric DNA binding by an orphan nuclear receptor. Mol Cell Biol 15:2517-2526.
61. Glass CK and Rosenfeld MG (2000) The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 14:121-141.
62. Gottlicher M, Heck S, and Herrlich P (1998) Transcriptional cross-talk, the second mode of steroid hormone receptor action. J Mol Med 76:480-489.
63. Green S, Kumar V, Theulaz I, Wahli W, and Chambon P (1988) The N-terminal DNA-binding 'zinc finger' of the oestrogen and glucocorticoid receptors determines target gene specificity. EMBO (Eur Mol Biol Organ) J 7:3037-3044.
64. Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P, and Chambon P (1986) Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature (Lond) 320:134-139.
65. Greene GL, Gilna P, Waterfield M, Baker A, Hort Y, and Shine J (1986) Sequence and expression of human estrogen receptor complementary DNA. Science (Wash DC) 231:1150-1154.
66. Greschik H, Flaig R, Renaud JP, and Moras D (2004) Structural basis for the deactivation of the estrogen-related receptor γ by diethylstilbestrol or 4-hydroxytamoxifen and determinants of selectivity. J Biol Chem 279:33639-33646.
67. Gronemeyer H, Gustafsson JA, and Laudet V (2004) Principles for modulation of the nuclear receptor superfamily. Nat Rev Drug Discov 3:950-964.
68. Haffner SM, Greenberg AS, Weston WM, Chen H, Williams K, and Freed MI (2002) Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus. Circulation 106:679-684.
69. Hager GL, Nagaich AK, Johnson TA, Walker DA, and John S (2004) Dynamics of nuclear receptor movement and transcription. Biochim Biophys Acta 1677:46-51.
70. Harding HP and Lazar MA (1995) The monomer-binding orphan receptor Rev-Erb represses transcription as a dimer on a novel direct repeat. Mol Cell Biol 15:4791-4802.
71. Hartman HB, Yu J, Alenghat T, Ishizuka T, and Lazar MA (2005) The histone-binding code of nuclear receptor co-repressors matches the substrate specificity of histone deacetylase 3. EMBO Rep 6:445-451.
72. Heery DM, Kalkhoven E, Hoare S, and Parker MG (1997) A signature motif in transcriptional co-activators mediates binding to nuclear receptor. Nature (Lond) 387:733-736.
73. Hermanson O, Glass CK, and Rosenfeld MG (2002) Nuclear receptor coregulators: multiple modes of modification. Trends Endocrinol Metab 13:55-60.
74. Herrlich P (2001) Cross-talk between glucocorticoid receptor and AP-1. Oncogene 20:2465-2475.
75. Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, Thompson EB, Rosenfeld MG, and Evans RM (1985) Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature (Lond) 318:635-641.
76. Hong SH and Privalsky ML (2000) The SMRT corepressor is regulated by a MEK-1 kinase pathway: inhibition of corepressor function is associated with SMRT phosphorylation and nuclear export. Mol Cell Biol 20:6612-6625.
77. Hopp TA and Fuqua SA (1998) Estrogen receptor variants. J Mamm Gland Biol Neoplasia 3:73-83.
78. Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Soderstrom M, Glass CK, et al. (1995) Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature (Lond) 377:397-404.
79. Hu X and Lazar MA (1999) The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature (Lond) 402:93-96.
80. Huang SM, Huang CJ, Wang WM, Kang JC, and Hsu WC (2004) The enhancement of nuclear receptor transcriptional activation by a mouse actin-binding protein, α actinin 2. J Mol Endocrinol 32:481-496.
81. Ikonen T, Palvimo JJ, and Janne OA (1997) Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators. J Biol Chem 272:29821-29828.
82. Improta-Brears T, Whorton AR, Codazzi F, York JD, Meyer T, and McDonnell DP (1999) Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. Proc Natl Acad Sci USA 96:4686-4691.
83. Issemann I and Green S (1990) Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature (Lond) 347:645-650.
84. Jackson TA, Richer JK, Bain DL, Takimoto GS, Tung L, and Horwitz KB (1997) The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT. Mol Endocrinol 11:693-705.
85. Jensen EV (1962) On the mechanism of estrogen action. Perspect Biol Med 6:47-59.
86. Jensen EV and Khan SA (2004) A two-site model for antiestrogen action. Mech Ageing Dev 125:679-682.
87. Kallen JA, Schlaeppi JM, Bitsch F, Geisse S, Geiser M, Delhon I, and Fournier B (2002) X-ray structure of the hRORα LBD at 1.63 A: structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORα. Structure 10:1697-1707.
88. Kang Z, Pirskanen A, Janne OA, and Palvimo JJ (2002) Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex. J Biol Chem 277:48366-483671.
89. Keeton EK and Brown M (2005) Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-α and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT. Mol Endocrinol 19:1543-1554.
90. Kelly MJ and Levin ER (2001) Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol Metab 12:152-156.
91. Khorasanizadeh S (2004) The nucleosome: from genomic organization to genomic regulation. Cell 116:259-272.
92. Klein ES, Pino ME, Johnson AT, Davies PJ, Nagpal S, Thacher SM, Krasinski G, and Chandraratna RA (1996) Identification and functional separation of retinoic acid receptor neutral antagonists and inverse agonists. J Biol Chem 271:22692-22696.
93. Kliewer SA, Forman BM, Blumberg B, Ong ES, Borgmeyer U, Mangelsdorf DJ, Umesono K, and Evans RM (1994) Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA 91:7355-7359.
94. Kliewer SA, Lehmann JM, and Willson TM (1999) Orphan nuclear receptors: shifting endocrinology into reverse. Science (Wash DC) 284:757-760.
95. Knutti D, Kressler D, and Kralli A (2001) Regulation of the transcriptional coactivator PGC-1 via MAPK-sensitive interaction with a repressor. Proc Natl Acad Sci USA 98:9713-9718.
96. Koh SS, Chen D, Lee YH, and Stallcup MR (2001) Synergistic enhancement of nuclear receptor function by p160 coactivators and two coactivators with protein methyltransferase activities. J Biol Chem 276:1089-1098.
97. Kousteni S, Bellido T, Plotkin LI, O'Brien CA, Bodenner DL, Han L, Han K, DiGregorio GB, Katzenellenbogen JA, Katzenellenbogen BS, et al. (2001) Non-genotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104:719-730.
98. Kouzarides T (2000) Acetylation: a regulatory modification to rival phosphorylation? EMBO (Eur Mol Biol Organ) J 19:1176-1179.
99. Kraus WL and Wong J (2002) Nuclear receptor-dependent transcription with chromatin: is it all about enzymes? Eur J Biochem 269:2275-2283.
100. Krylova IN, Sablin EP, Moore J, Xu RX, Waitt GM, MacKay JA, Juzumiene D, Bynum JM, Madauss K, Montana V, et al. (2005) Structural analyses reveal phosphatidyl inositols as ligands for the NR5 orphan receptors SF-1 and LRH-1. Cell 120:343-355.
101. Krust A, Green S, Argos P, Kumar V, Walter P, Bornert JM, and Chambon P (1986) The chicken oestrogen receptor sequence: homology with v-erbA and the human oestrogen and glucocorticoid receptors. EMBO (Eur Mol Biol Organ) J 5:891-897.
102. Kumar R, Wang RA, and Barnes CJ (2004) Coregulators and chromatin remodeling in transcriptional control. Mol Carcinog 41:221-230.
103. +-regulated dehydrogenase. Mol Cell 10:857-869.
104. Kumar V, Green S, Staub A, and Chambon P (1986) Localisation of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor. EMBO (Eur Mol Biol Organ) J 5:2231-2236.
105. Lanz RB, McKenna NJ, Onate SA, Albrecht U, Wong J, Tsai SY, Tsai MJ, and O'Malley BW (1999) A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell 97:17-27.
106. Laudet V (1997) Evolution of the nuclear receptor superfamily: early diversification from an ancestral orphan receptor. J Mol Endocrinol 19:207-226.
107. Laudet V and Gronemeyer H (2002) The Nuclear receptor Facts Book, Academic Press, San Diego.
108. Lavinsky RM, Jepsen K, Heinzel T, Torchia J, Mullen TM, Schiff R, Del-Rio AL, Ricote M, Ngo S, Gemsch J, et al. (1998) Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc Natl Acad Sci USA 95:2920-2925.
109. Law SW, Conneely OM, DeMayo FJ, and O'Malley BW (1992) Identification of a new brain-specific transcription factor, NURR1. Mol Endocrinol 6:2129-2135.
110. Lee YH, Campbell HD, and Stallcup MR (2004) Developmentally essential protein flightless I is a nuclear receptor coactivator with actin binding activity. Mol Cell Biol 24:2103-2117.
111. Li Y, Choi M, Cavey G, Daugherty J, Suino K, Kovach A, Bingham NC, Kliewer SA, and Xu HE (2005) Crystallographic identification and functional characterization of phospholipids as ligands for the orphan nuclear receptor steroidogenic factor-1. Mol Cell 17:491-502.
112. Li Y, Lambert MH, and Xu HE (2003) Activation of nuclear receptors: a perspective from structural genomics. Structure 11:741-746.
113. Lin HK, Altuwaijri S, Lin WJ, Kan PY, Collins LL, and Chang C (2002) Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells. J Biol Chem 277:36570-36576.
114. Lin HY, Zhang S, West BL, Tang HY, Passaretti T, Davis FB, and Davis PJ (2003) Identification of the putative MAP kinase docking site in the thyroid hormone receptor-β1 DNA-binding domain: functional consequences of mutations at the docking site. Biochemistry 42:7571-7579.
115. Liu XF and Bagchi MK (2004) Recruitment of distinct chromatin-modifying complexes by tamoxifen-complexed estrogen receptor at natural target gene promoters in vivo. J Biol Chem 279:15050-15058.
116. Liu Z, Auboeuf D, Wong J, Chen JD, Tsai SY, Tsai MJ, and O'Malley BW (2002) Coactivator/corepressor ratios modulate PR-mediated transcription by the selective receptor modulator RU486. Proc Natl Acad Sci USA 99:7940-7944.
117. Lonard DM, Nawaz Z, Smith CL, and O'Malley BW (2000) The 26S proteasome is required for estrogen receptor-α and coactivator turnover and for efficient estrogen receptor-α transactivation. Mol Cell 5:939-948.
118. Lopez GN, Turck CW, Schaufele F, Stallcup MR, and Kushner PJ (2001) Growth factors signal to steroid receptors through mitogen-activated protein kinase regulation of p160 coactivator activity. J Biol Chem 276:22177-22182.
119. Loy CJ, Sim KS, and Yong EL (2003) Filamin-A fragment localizes to the nucleus to regulate androgen receptor and coactivator functions. Proc Natl Acad Sci USA 100:4562-4567.
120. Luisi BF, Xu WX, Otwinowski Z, Freedman LP, Yamamoto KR, and Sigler PB (1991) Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature (Lond) 352:497-505.
121. Mader S, Chen JY, Chen Z, White J, Chambon P, and Gronemeyer H (1993) The patterns of binding of RAR, RXR and TR homo- and heterodimers to direct repeats are dictated by the binding specificities of the DNA binding domains. EMBO (Eur Mol Biol Organ) J 12:5029-5041.
122. Malik S and Roeder RG (2000) Transcriptional regulation through mediator-like coactivators in yeast and metazoan cells. Trends Biochem Sci 25:277-283.
123. Mangelsdorf DJ and Evans RM (1995) The RXR heterodimers and orphan receptors. Cell 83:841-850.
124. Mani S (2001) Ligand-independent activation of progestin receptors in sexual receptivity. Horm Behav 40:183-190.
125. Maruvada P, Baumann CT, Hager GL, and Yen PM (2003) Dynamic shuttling and intranuclear mobility of nuclear hormone receptors. J Biol Chem 278:12425-12432.
126. Mcinerney EM and Katzenellenbogen BS (1996) Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation. J Biol Chem 271:24172-24178.
127. McKay LI and Cidlowski JA (1999) Molecular control of immune/inflammatory responses: interactions between nuclear factor-κB and steroid receptor-signaling pathways. Endocr Rev 20:435-459.
128. McKenna NJ and O'Malley BW (2002) Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108:465-474.
129. McLachlan JA (2001) Environmental signaling: what embryos and evolution teach us about endocrine disrupting chemicals. Endocr Rev 22:319-341.
130. McNally JG, Muller WG, Walker D, Wolford R, and Hager GL (2000) The glucocorticoid receptor: rapid exchange with regulatory sites in living cells. Science (Wash DC) 287:1262-1265.
131. Metivier R, Penot G, Hubner MR, Reid G, Brand H, Kos M, and Gannon F (2003) Estrogen receptor-α directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115:751-763.
132. Metivier R, Reid G, and Gannon F (2006) Transcription in four dimensions: nuclear receptor-directed initiation of gene expression. EMBO (Eur Mol Biol Organ) Rep 7:161-167.
133. Metzger D, Losson R, Bornert JM, Lemoine Y, and Chambon P (1992) Promoter specificity of the two transcriptional activation functions of the human oestrogen receptor in yeast. Nucleic Acids Res 20:2813-2817.
134. Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, Nola E, and Auricchio F (1996) Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO (Eur Mol Biol Organ) J 15:1292-1300.
135. Molinari E, Gilman M, and Natesan S (1999) Proteasome-mediated degradation of transcriptional activators correlates with activation domain potency in vivo. EMBO (Eur Mol Biol Organ) J 18:6439-6447.
136. Morgan DO (1995) Principles of CDK regulation. Nature (Lond) 374:131-134.
137. Nagaich AK, Walker DA, Wolford R, and Hager GL (2004) Rapid periodic binding and displacement of the glucocorticoid receptor during chromatin remodeling. Mol Cell 14:163-174.
138. Nagy L and Schwabe JW (2004) Mechanism of the nuclear receptor molecular switch. Trends Biochem Sci 29:317-324.
139. Nawaz Z, Lonard DM, Dennis AP, Smith CL, and O'Malley BW (1999) Proteasome-dependent degradation of the human estrogen receptor. Proc Natl Acad Sci USA 96:1858-1862.
140. Nishimura K, Ting HJ, Harada Y, Tokizane T, Nonomura N, Kang HY, Chang HC, Yeh S, Miyamoto H, Shin M, et al. (2003) Modulation of androgen receptor transactivation by gelsolin: a newly identified androgen receptor coregulator. Cancer Res 63:4888-4894.
141. Nolte RT, Wisely GB, Westin S, Cobb JE, Lambert MH, Kurokawa R, Rosenfeld MG, Willson TM, Glass CK, and Milburn MV (1998) Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ. Nature (Lond) 395:137-143.
142. Nuclear Receptor Nomenclature Committee (1999) A unified nomenclature system for the nuclear receptor superfamily. Cell 97:161-163.
143. Ordentlich P, Downes M, Xie W, Genin A, Spinner NB, and Evans RM (1999) Unique forms of human and mouse nuclear receptor corepressor SMRT. Proc Natl Acad Sci USA 96:2639-2644.
144. Ortlund EA, Lee Y, Solomon IH, Hager JM, Safi R, Choi Y, Guan Z, Tripathy A, Raetz CR, McDonnell DP, et al. (2005) Modulation of human nuclear receptor LRH-1 activity by phospholipids and SHP. Nat Struct Mol Biol 12:357-363.
145. Otte K, Kranz H, Kober I, Thompson P, Hoefer M, Haubold B, Remmel B, Voss H, Kaiser C, Albers M, et al. (2003) Identification of farnesoid X receptor beta as a novel mammalian nuclear receptor sensing lanosterol. Mol Cell Biol 23:864-872.
146. Owen GI and Zelent A (2000) Origins and evolutionary diversification of the nuclear receptor superfamily. Cell Mol Life Sci 57:809-827.
147. Park EJ, Schroen DJ, Yang M, Li H, Li L, and Chen JD (1999) SMRTe, a silencing mediator for retinoid and thyroid hormone receptors-extended isoform that is more related to the nuclear receptor corepressor. Proc Natl Acad Sci USA 96:3519-3524.
148. Park KJ, Krishnan V, O'Malley BW, Yamamoto Y, and Gaynor RB (2005) Formation of an IKKα-dependent transcription complex is required for estrogen receptor-mediated gene activation. Mol Cell 18:71-82.
149. Pascual G, Fong AL, Ogawa S, Gamliel A, Li AC, Perissi V, Rose DW, Willson TM, Rosenfeld MG, and Glass CK (2005) A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ. Nature (Lond) 437:759-763.
150. Pearce D, Matsui W, Miner JN, and Yamamoto KR (1998) Glucocorticoid receptor transcriptional activity determined by spacing of receptor and nonreceptor DNA sites. J Biol Chem 273:30081-30085.
151. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, and Cobb MH (2001) Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22:153-183.
152. Perissi V and Rosenfeld MG (2005) Controlling nuclear receptors: the circular logic of cofactor cycles. Nat Rev Mol Cell Biol 6:542-554.
153. Perissi V, Staszewski LM, McInerney EM, Kurokawa R, Krones A, Rose DW, Lambert MH, Milburn MV, Glass CK, and Rosenfeld MG (1999) Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev 13:3198-3208.
154. Perkins TJ, Hallett M, and Glass L (2004) Inferring models of gene expression dynamics. J Theor Biol 230:289-299.
155. Perlmann T and Jansson L (1995) A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1. Genes Dev 9:769-782.
156. Perlmann T, Rangarajan PN, Umesono K, and Evans RM (1993) Determinants for selective RAR and TR recognition of direct repeat HREs. Genes Dev 7:1411-1422.
157. Philips A, Lesage S, Gingras R, Maira MH, Gauthier Y, Hugo P, and Drouin J (1997) Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells. Mol Cell Biol 17:5946-5951.
158. Picard D (1998) Molecular endocrinology: steroids tickle cells inside and out. Nature (Lond) 392:437-438.
159. Pike AC, Brzozowski AM, Walton J, Hubbard RE, Thorsell AG, Li YL, Gustafsson JA, and Carlquist M (2001) Structural insights into the mode of action of a pure antiestrogen. Structure 9:145-153.
160. Pratt WB and Toft DO (1997) Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev 18:306-360.
161. Privalsky ML (2004) The role of corepressors in transcriptional regulation by nuclear hormone receptors. Annu Rev Physiol 66:315-360.
162. Rachez C, Lemon BD, Suldan Z, Bromleigh V, Gamble M, Naar AM, Erdjument-Bromage H, Tempst P, and Freedman LP (1999) Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature (Lond) 398:824-828.
163. Rastinejad F, Perlmann T, Evans RM, and Sigler PB (1995) Structural determinants of nuclear receptor assembly on DNA direct repeats. Nature (Lond) 375:203-211.
164. Rastinejad F, Wagner T, Zhao Q, and Khorasanizadeh S (2000) Structure of the RXR-RAR DNA-binding complex on the retinoic acid response element DR1. EMBO (Eur Mol Biol Organ) J 19:1045-1054.
165. Rayasam GV, Elbi C, Walker DA, Wolford R, Fletcher TM, Edwards DP, and Hager GL (2005) Ligand-specific dynamics of the progesterone receptor in living cells and during chromatin remodeling in vitro. Mol Cell Biol 25:2406-2418.
166. Reichardt HM, Kaestner KH, Tuckermann J, Kretz O, Wessely O, Bock R, Gass P, Schmid W, Herrlich P, Angel P, et al. (1998) DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93:531-541.
167. Reichardt HM, Tronche F, Berger S, Kellendonk C, and Schutz G (2000) New insights into glucocorticoid and mineralocorticoid signaling: lessons from gene targeting. Adv Pharmacol 47:1-21.
168. Reid G, Hubner MR, Metivier R, Brand H, Denger S, Manu D, Beaudouin J, Ellenberg J, and Gannon F (2003) Cyclic, proteasome-mediated turnover of
169. Robinson-Rechavi M, Carpentier AS, Duffraise M, and Laudet V (2001) How many nuclear hormone receptors are there in the human genome? Trends Genet 17:554-556.
170. Rochette-Egly C, Oulad-Abdelghani M, Staub A, Pfister V, Scheuer I, Chambon P, and Gaub MP (1995) Phosphorylation of the retinoic acid receptor-α by protein kinase A. Mol Endocrinol 9:860-871.
171. Roeder RG (1996) The role of general initiation factors in transcription by RNA polymerase II. Trends Biochem Sci 21:327-335.
172. Rowan BG, Weigel NL, and O'Malley BW (2000) Phosphorylation of steroid receptor coactivator-1: identification of the phosphorylation sites and phosphorylation through the mitogen-activated protein kinase pathway. J Biol Chem 275:4475-4483.
173. Sablin EP, Krylova IN, Fletterick RJ, and Ingraham HA (2003) Structural basis for ligand-independent activation of the orphan nuclear receptor LRH-1. Mol Cell 11:1575-1585.
174. Salghetti SE, Muratani M, Wijnen H, Futcher B, and Tansey WP (2000) Functional overlap of sequences that activate transcription and signal ubiquitin-mediated proteolysis. Proc Natl Acad Sci USA 97:3118-3123.
175. Schaaf MJ and Cidlowski JA (2003) Molecular determinants of glucocorticoid receptor mobility in living cells: the importance of ligand affinity. Mol Cell Biol 23:1922-1934.
176. Schmidt A, Endo N, Rutledge SJ, Vogel R, Shinar D, and Rodan GA (1992) Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids. Mol Endocrinol 6:1634-1641.
177. Schwabe JW, Chapman L, Finch JT, and Rhodes D (1993) The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements. Cell 75:567-578.
178. Schwartz HL, Carter AC, Kydd DM, and Gordon AS (1967) Relationship of red blood cell 131-I-L-triiodothyronine binding coefficient and cell maturation. II. Effect of cell age and metabolic inhibitors. Endocrinology 80:65-68.
179. Shaffer PL and Gewirth DT (2002) Structural basis of VDR-DNA interactions on direct repeat response elements. EMBO (Eur Mol Biol Organ) J 21:2242-2252.
180. Shang Y and Brown M (2002) Molecular determinants for the tissue specificity of SERMs. Science (Wash DC) 295:2465-2468.
181. Shang Y, Hu X, DiRenzo J, Lazar MA, and Brown M (2000) Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103:843-852.
182. Shaulian E and Karin M (2002) AP-1 as a regulator of cell life and death. Nat Cell Biol 4:E131-6.
183. Shemshedini L, Knauthe R, Sassone-Corsi P, Pornon A, and Gronemeyer H (1991) Cell-specific inhibitory and stimulatory effects of Fos and Jun on transcription activation by nuclear receptors. EMBO (Eur Mol Biol Organ) J 10:3839-3849.
184. Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, and Greene GL (1998) The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95:927-937.
185. Shiau AK, Barstad D, Radek JT, Meyers MJ, Nettles KW, Katzenellenbogen BS, Katzenellenbogen JA, Agard DA, and Greene GL (2002) Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism. Nat Struct Biol 9:359-364.
186. Shulman AI, Larson C, Mangelsdorf DJ, and Ranganathan R (2004) Structural determinants of allosteric ligand activation in RXR heterodimers. Cell 116:417-429.
187. Simental JA, Sar M, Lane MV, French FS, and Wilson EM (1991) Transcriptional activation and nuclear targeting signals of the human androgen receptor. J Biol Chem 266:510-518.
188. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, and Liao JK (2000) Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature (Lond) 407:538-541.
189. Smith CL, Nawaz Z, and O'Malley BW (1997) Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol Endocrinol 11:657-666.
190. Smith CL and O'Malley BW (2004) Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr Rev 25:45-71.
191. Stanley TB, Leesnitzer LM, Montana VG, Galardi CM, Lambert MH, Holt JA, Xu HE, Moore LB, Blanchard SG, and Stimmel JB (2003) Subtype specific effects of peroxisome proliferator-activated receptor ligands on corepressor affinity. Biochemistry 42:9278-9287.
192. Strahl BD and Allis CD (2000) The language of covalent histone modifications. Nature (Lond) 403:41-45.
193. Takeyama K, Kitanaka S, Sato T, Kobori M, Yanagisawa J, and Kato S (1997) 25-Hydroxyvitamin D3 1α-hydroxylase and vitamin D synthesis. Science (Wash DC) 277:1827-1830.
194. Tan JA, Hall SH, Hamil KG, Grossman G, Petrusz P, and French FS (2002) Protein inhibitors of activated STAT resemble scaffold attachment factors and function as interacting nuclear receptor coregulators. J Biol Chem 277:16993-17001.
195. Tang HY, Lin HY, Zhang S, Davis FB, and Davis PJ (2004) Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor. Endocrinology 145:3265-3272.
196. Thompson PD, Jurutka PW, Haussler CA, Whitfield GK, and Haussler MR (1998) Heterodimeric DNA binding by the vitamin D receptor and retinoid X receptors is enhanced by 1,25-dihydroxyvitamin D3 and inhibited by 9-cis-retinoic acid: evidence for allosteric receptor interactions. J Biol Chem 273:8483-8491.
197. Thornton JW and DeSalle R (2000) A new method to localize and test the significance of incongruence: detecting domain shuffling in the nuclear receptor superfamily. Syst Biol 49:183-201.
198. Ting HJ, Yeh S, Nishimura K, and Chang C (2002) Supervillin associates with androgen receptor and modulates its transcriptional activity. Proc Natl Acad Sci USA 99:661-666.
199. Towers TL, Luisi BF, Asianov A, and Freedman LP (1993) DNA target selectivity by the vitamin D3 receptor: mechanism of dimer binding to an asymmetric repeat element. Proc Natl Acad Sci USA 90:6310-6314.
200. Turner BM (2002) Cellular memory and the histone code. Cell 111:285-291.
201. Umesono K and Evans RM (1989) Determinants of target gene specificity for steroid/thyroid hormone receptors. Cell 57:1139-1146.
202. Valverde MA, Rojas P, Amigo J, Cosmelli D, Orio P, Bahamonde MI, Mann GE, Vergara C, and Latorre R (1999) Acute activation of Maxi-K channels (hSlo) by estradiol binding to the β subunit. Science (Wash DC) 285:1929-1931.
203. Vaquero A, Loyola A, and Reinberg D (2003) The constantly changing face of chromatin. Sci Aging Knowledge Environ 2003:RE4.
204. Vo N, Fjeld C, and Goodman RH (2001) Acetylation of nuclear hormone receptor-interacting protein RIP140 regulates binding of the transcriptional corepressor CtBP. Mol Cell Biol 21:6181-6188.
205. Vo N and Goodman RH (2001) CREB-binding protein and p300 in transcriptional regulation. J Biol Chem 276:13505-13508.
206. Wang C, Fu M, Angeletti RH, Siconolfi-Baez L, Reutens AT, Albanese C, Lisanti MP, Katzenellenbogen BS, Kato S, Hopp T, et al. (2001a) Direct acetylation of the estrogen receptor α hinge region by p300 regulates transactivation and hormone sensitivity. J Biol Chem 276:18375-18383.
207. Wang H, Huang ZQ, Xia L, Feng Q, Erdjument-Bromage H, Strahl BD, Briggs SD, Allis CD, Wong J, Tempst P, et al. (2001b) Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science (Wash DC) 293:853-857.
208. Wang Z, Benoit G, Liu J, Prasad S, Aarnisalo P, Liu X, Xu H, Walker NP, and Perlmann T (2003) Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors. Nature (Lond) 423:555-560.
209. Webb P, Nguyen P, and Kushner PJ (2003) Differential SERM effects on corepressor binding dictate ERα activity in vivo. J Biol Chem 278:6912-6920.
210. Webb P, Nguyen P, Shinsako J, Anderson C, Feng W, Nguyen MP, Chen D, Huang SM, Subramanian S, McKinerney E, et al. (1998) Estrogen receptor activation function 1 works by binding p160 coactivator proteins. Mol Endocrinol 12:1605-1618.
211. Wehling M (1997) Specific, nongenomic actions of steroid hormones. Annu Rev Physiol 59:365-393.
212. Weigel NL and Zhang Y (1998) Ligand-independent activation of steroid hormone receptors. J Mol Med 76:469-479.
213. White JH, Fernandes I, Mader S, and Yang XJ (2004) Corepressor recruitment by agonist-bound nuclear receptors. Vitam Horm 68:123-143.
214. Wilson TE, Fahrner TJ, and Milbrandt J (1993) The orphan receptors NGFI-B and steroidogenic factor 1 establish monomer binding as a third paradigm of nuclear receptor-DNA interaction. Mol Cell Biol 13:5794-5804.
215. Wisely GB, Miller AB, Davis RG, Thornquest AD Jr, Johnson R, Spitzer T, Sefler A, Shearer B, Moore JT, Willson TM, et al. (2002) Hepatocyte nuclear factor 4 is a transcription factor that constitutively binds fatty acids. Structure 10:1225-1234.
216. Xu HE, Lambert MH, Montana VG, Parks DJ, Blanchard SG, Brown PJ, Sternbach DD, Lehmann JM, Wisely GB, Willson TM, et al. (1999) Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol Cell 3:397-403.
217. Xu HE, Stanley TB, Montana VG, Lambert MH, Shearer BG, Cobb JE, McKee DD, Galardi CM, Plunket KD, Nolte RT, et al. (2002) Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARα. Nature (Lond) 415:813-817.
218. Xu W, Cho H, Kadam S, Banayo EM, Anderson S, Yates JR 3rd, Emerson BM, and Evans RM (2004) A methylation-mediator complex in hormone signaling. Genes Dev 18:144-156.
219. Yamamoto Y, Wada O, Suzawa M, Yogiashi Y, Yano T, Kato S, and Yanagisawa J (2001) The tamoxifen-responsive estrogen receptor α mutant D351Y shows reduced tamoxifen-dependent interaction with corepressor complexes. J Biol Chem 276:42684-42691.
220. Yan F, Gao X, Lonard DM, and Nawaz Z (2003) Specific ubiquitin- conjugating enzymes promote degradation of specific nuclear receptor coactivators. Mol Endocrinol 17:1315-1331.
221. 3 receptor. J Biol Chem 274:16838-16845.
222. Yoon HG, Chan DW, Huang ZQ, Li J, Fondell JD, Qin J, and Wong J (2003) Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1. EMBO (Eur Mol Biol Organ) J 22:1336-1346.
223. Yuan CX, Ito M, Fondell JD, Fu ZY, and Roeder RG (1998) The TRAP220 component of a thyroid hormone receptor-associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion. Proc Natl Acad Sci USA 95:7939-7944. [Published erratum appears in Proc Natl Acad Sci USA (1998) 95:14584.]
224. Yuan LW and Gambee JE (2000) Phosphorylation of p300 at serine 89 by protein kinase C. J Biol Chem 275:40946-40951.
225. Zechel C, Shen XQ, Chambon P, and Gronemeyer H (1994a) Dimerization interfaces formed between the DNA binding domains determine the cooperative binding of RXR/RAR and RXR/TR heterodimers to DR5 and DR4 elements. EMBO (Eur Mol Biol Organ) J 13:1414-1424.
226. Zechel C, Shen XQ, Chen JY, Chen ZP, Chambon P, and Gronemeyer H (1994b) The dimerization interfaces formed between the DNA binding domains of RXR, RAR and TR determine the binding specificity and polarity of the full-length receptors to direct repeats. EMBO (Eur Mol Biol Organ) J 13:1425-1433.
227. Zhang X, Jeyakumar M, Petukhov S, and Bagchi MK (1998) A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor. Mol Endocrinol 12:513-524.
228. Zhao Q, Chasse SA, Devarakonda S, Sierk ML, Ahvazi B, and Rastinejad F (2000) Structural basis of RXR-DNA interactions. J Mol Biol 296:509-520.
229. Zhou Y, Gross W, Hong SH, and Privalsky ML (2001) The SMRT corepressor is a target of phosphorylation by protein kinase CK2 (casein kinase II). Mol Cell Biochem 220:1-13.
230. Zhu J, Gianni M, Kopf E, Honore N, Chelbi-Alix M, Koken M, Quignon F, Rochette-Egly C, and de The H (1999) Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor α (RARα) and oncogenic RARα fusion proteins. Proc Natl Acad Sci USA 96:14807-14812.
231. Zilliacus J, Carlstedt-Duke J, Gustafsson JA, and Wright AP (1994) Evolution of distinct DNA-binding specificities within the nuclear receptor family of transcription factors. Proc Natl Acad Sci USA 91:4175-4179.